Summit Therapeutics Inc (SMMT)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track

Stock chart

Ticker: SMMT Exchange: NMS

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings

Earnings

Value bought

Past 90 days

Value sold

Past 90 days

Net insiders buying

Past 90 days

Trades (buy and sell)

Past 90 days

Company data

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2024-03-27	2024-03-27	B Purchase	Zanganeh Mahkam Chief Executive Officer Executive Director	20,000 +66.7% 3.71 USD 74,200	20,000 +66.7%	3.71	USD 74,200
2024-03-27	2024-03-27	B Purchase	Zanganeh Mahkam Chief Executive Officer Executive Director	34,321 +0.1% 3.72 USD 127,674	34,321 +0.1%	3.72	USD 127,674
2024-03-27	2024-03-27	B Purchase	Zanganeh Mahkam Chief Executive Officer Executive Director	26,000 +5.3% 3.72 USD 96,720	26,000 +5.3%	3.72	USD 96,720
2024-03-27	2024-03-26	B Purchase	Dhingra Ankur Chief Financial Officer Officer	100,000 +39.2% 3.75 USD 375,000	100,000 +39.2%	3.75	USD 375,000
2024-03-27	2024-03-26	B Purchase	Zanganeh Mahkam Chief Executive Officer Executive Director	30,000 +inf% 3.75 USD 112,500	30,000 +inf%	3.75	USD 112,500
2023-12-13	2023-12-13	B Purchase	Dhingra Ankur Chief Financial Officer Officer	19,700 +8.4% 2.17 USD 42,749	19,700 +8.4%	2.17	USD 42,749
2023-12-13	2023-12-13	B Purchase	Dhingra Ankur Chief Financial Officer Officer	700 +0.3% 2.15 USD 1,505	700 +0.3%	2.15	USD 1,505
2023-12-13	2023-12-12	B Purchase	Zanganeh Mahkam Chief Executive Officer Executive Director	5,000 +1.0% 2.07 USD 10,350	5,000 +1.0%	2.07	USD 10,350
2023-10-16	2023-10-13	B Purchase	Soni Manmeet Singh Chief Operating Officer Executive Director	2,976,190 +inf% 1.68 USD 4,999,999	2,976,190 +inf%	1.68	USD 4,999,999
2023-03-08	2023-03-08	B Purchase	Zanganeh Mahkam Co-Chief Executive Officer Executive Director	6,748,629 +215.2% 1.05 USD 7,086,060	6,748,629 +215.2%	1.05	USD 7,086,060
2023-03-08	2023-03-08	B Purchase	Zanganeh Mahkam Co-Chief Executive Officer Executive Director	804,672 +215.2% 1.05 USD 844,906	804,672 +215.2%	1.05	USD 844,906
2023-03-08	2023-03-08	B Purchase	Zanganeh Mahkam Co-Chief Executive Officer Executive Director	15,973,743 +215.2% 1.05 USD 16,772,430	15,973,743 +215.2%	1.05	USD 16,772,430
2023-03-08	2023-03-07	B Purchase	Dhingra Ankur Chief Financial Officer Officer	196,362 +514.1% 1.05 USD 206,180	196,362 +514.1%	1.05	USD 206,180
2023-03-08	2023-03-06	B Purchase	DUGGAN ROBERT W Chief Executive Officer Executive Director	376,489,880 +214.1% 1.05 USD 395,314,374	376,489,880 +214.1%	1.05	USD 395,314,374
2022-08-18	2022-08-16	B Purchase	Zanganeh Maky Co-CEO & President Executive Director	1,030,925 +49.0% 0.97 USD 999,997	1,030,925 +49.0%	0.97	USD 999,997
2022-08-18	2022-08-16	B Purchase	Zanganeh Maky Co-CEO & President Executive Director	4,593,777 +186.2% 0.97 USD 4,455,964	4,593,777 +186.2%	0.97	USD 4,455,964
2022-08-18	2022-08-16	B Purchase	Zanganeh Maky Co-CEO & President Executive Director	184,430 +105.1% 0.97 USD 178,897	184,430 +105.1%	0.97	USD 178,897
2022-08-18	2022-08-16	B Purchase	DUGGAN ROBERT W Chief Executive Officer Executive Director	94,849,203 +140.1% 0.97 USD 92,003,727	94,849,203 +140.1%	0.97	USD 92,003,727
2022-08-17	2022-08-16	B Purchase	Dhingra Ankur Chief Financial Officer Officer	24,658 +182.1% 0.97 USD 23,918	24,658 +182.1%	0.97	USD 23,918
2022-08-17	2022-08-16	B Purchase	Dhingra Ankur Chief Financial Officer Officer	11,557 +43.6% 0.97 USD 11,210	11,557 +43.6%	0.97	USD 11,210
2021-05-14	2021-05-12	B Purchase	Zanganeh Maky Chief Operating Officer Executive Director	389,077 +17.3% 5.24 USD 2,038,763	389,077 +17.3%	5.24	USD 2,038,763
2021-05-14	2021-05-12	B Purchase	DUGGAN ROBERT W Chief Executive Officer Executive Director Large shareholder	11,365,921 +20.2% 5.24 USD 59,557,426	11,365,921 +20.2%	5.24	USD 59,557,426
2020-12-01	2020-11-30	S Sale	Powell David Jonathan Chief Scientific Officer Officer	13,713 -100.0% 4.44 USD 60,886	13,713 -100.0%	4.44	USD 60,886
2020-12-01	2020-11-27	S Sale	Powell David Jonathan Chief Scientific Officer Officer	29,569 -100.0% 4.39 USD 129,808	29,569 -100.0%	4.39	USD 129,808
2020-11-25	2020-11-25	S Sale	Powell David Jonathan Chief Scientific Officer Officer	12,070 -100.0% 4.32 USD 52,142	12,070 -100.0%	4.32	USD 52,142
2020-11-25	2020-11-24	S Sale	Powell David Jonathan Chief Scientific Officer Officer	11,374 -100.0% 4.21 USD 47,885	11,374 -100.0%	4.21	USD 47,885
2020-11-25	2020-11-23	S Sale	Powell David Jonathan Chief Scientific Officer Officer	6,987 -100.0% 4.40 USD 30,743	6,987 -100.0%	4.40	USD 30,743
2020-11-10	2020-11-06	B Purchase	DUGGAN ROBERT W Chief Executive Officer Executive Director Large shareholder	14,071,856 +33.3% 3.34 USD 46,999,999	14,071,856 +33.3%	3.34	USD 46,999,999

Summit Therapeutics Inc (SMMT)

Track

Stock chart

Earnings

Value bought

Value sold

Net insiders buying

Trades (buy and sell)

Transactions

Insider

Sort by